Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron Aug 03, 2021 5:27pm

100 Views

Post# 33646072

todays trades

House Positions for C:VXL from 20210803 to 20210803

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
2 RBC	63,700	5,639	0.089	38,714	3,424	0.088	24,986	-2,215
1 Anonymous	46,000	3,860	0.084	30,000	2,690	0.09	16,000	-1,170
89 Raymond James	9,514	856	0.09	0			9,514	-856
9 BMO Nesbitt	6,000	540	0.09	0			6,000	-540
19 Desjardins	1,500	127	0.085	0			1,500	-127
39 Merrill Lynch	625	53	0.085	0			625	-53
68 Leede	2,000	170	0.085	1,997	173	0.087	3	3
7 TD Sec	30,100	2,408	0.08	30,100	2,408	0.08	0	0
14 ITG	2,006	170	0.085	2,506	213	0.085	-500	43
85 Scotia	5,205	453	0.087	10,000	800	0.08	-4,795	347
33 Canaccord	0			8,000	720	0.09	-8,000	720
80 National Bank	8,052	690	0.086	53,385	4,540	0.085	-45,333	3,850
TOTAL	174,702	14,966	0.086	174,702	14,968	0.086	0	2